Cargando…
AR Signaling in Breast Cancer
Androgen receptor (AR, a member of the steroid hormone receptor family) status has become increasingly important as both a prognostic marker and potential therapeutic target in breast cancer. AR is expressed in up to 90% of estrogen receptor (ER) positive breast cancer, and to a lesser degree, human...
Autores principales: | Rahim, Bilal, O’Regan, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366816/ https://www.ncbi.nlm.nih.gov/pubmed/28245550 http://dx.doi.org/10.3390/cancers9030021 |
Ejemplares similares
-
New and emerging treatments for estrogen receptor-positive breast cancer: focus on everolimus
por: Paplomata, Elisavet, et al.
Publicado: (2013) -
The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy
por: Mitri, Zahi, et al.
Publicado: (2012) -
PI3Kinase Inhibition in Hormone Receptor-Positive Breast Cancer
por: Dhakal, Ajay, et al.
Publicado: (2021) -
Diverse roles of androgen receptor (AR) domains in AR-mediated signaling
por: Claessens, Frank, et al.
Publicado: (2008) -
AR-Signaling in Human Malignancies: Prostate Cancer and Beyond
por: Schweizer, Michael T., et al.
Publicado: (2017)